Literature DB >> 10419864

Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.

W A van der Reijden1, A Vissink, E C Veerman, A V Amerongen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10419864      PMCID： PMC1752926          DOI： 10.1136/ard.58.8.465

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  107 in total

1.  The effect of acupuncture on salivary flow rates in patients with xerostomia.

Authors:  M Blom; I Dawidson; B Angmar-Månsson
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1992-03

2.  Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjögrens syndrome.

Authors:  A S Papas; M M Fernandez; R A Castano; S C Gallagher; M Trivedi; R C Shrotriya
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

3.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

4.  Caries prevalence in xerostomic individuals.

Authors:  A S Papas; A Joshi; S L MacDonald; L Maravelis-Splagounias; P Pretara-Spanedda; F A Curro
Journal:  J Can Dent Assoc       Date:  1993-02       Impact factor: 1.316

5.  Effect of Sialor in treatment of xerostomia in Sjögren's syndrome.

Authors:  J B Epstein; W E Decoteau; A Wilkinson
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1983-11

6.  In vitro antifungal properties of mouthrinses containing antimicrobial agents.

Authors:  G Giuliana; G Pizzo; M E Milici; G C Musotto; R Giangreco
Journal:  J Periodontol       Date:  1997-08       Impact factor: 6.993

Review 7.  Salivary gland dysfunction: causes, symptoms, treatment.

Authors:  J C Atkinson; A J Wu
Journal:  J Am Dent Assoc       Date:  1994-04       Impact factor: 3.634

8.  Effect of pilocarpine on behavior of mucus glycoproteins of canine tracheal secretory cells.

Authors:  S Yanaura; H Takeda; T Nishimura; M Misawa
Journal:  Jpn J Pharmacol       Date:  1982-02

9.  Interactions of Candida albicans with bacteria and salivary molecules in oral biofilms.

Authors:  A R Holmes; R D Cannon; H F Jenkinson
Journal:  J Ind Microbiol       Date:  1995-09

10.  Dysphagia in patients with three different etiologies of salivary gland dysfunction.

Authors:  N L Rhodus; K Moller; S Colby; J Bereuter
Journal:  Ear Nose Throat J       Date:  1995-01       Impact factor: 1.697
View more
  10 in total

Review 1.  Therapy of Sjögren's syndrome.

Authors:  N M Moutsopoulos; H M Moutsopoulos
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.

Authors:  Ibtisam Al-Hashimi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment.

Authors:  Alessandro Villa; Andy Wolff; Doron Aframian; Arjan Vissink; Jörgen Ekström; Gordon Proctor; Richard McGowan; Nagamani Narayana; Ardita Aliko; Ying Wai Sia; Revan Kumar Joshi; Siri Beier Jensen; Alexander Ross Kerr; Colin Dawes; Anne Marie Lynge Pedersen
Journal:  Clin Oral Investig       Date:  2015-05-22       Impact factor: 3.573

4.  The efficacy of Xialine in patients with Sjögren's syndrome: a single-blind, cross-over study.

Authors:  Esin Alpöz; Pelin Güneri; Gonca Onder; Hülya Cankaya; Yasemin Kabasakal; Timur Köse
Journal:  Clin Oral Investig       Date:  2007-11-14       Impact factor: 3.573

Review 5.  Myelopathy in Sjögren's syndrome: role of nonsteroidal immunosuppressants.

Authors:  Susan J Rogers; Christopher S Williams; Gustavo C Román
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Medication-Induced Xerostomia and Hyposalivation in the Elderly: Culprits, Complications, and Management.

Authors:  Anna Greta Barbe
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923

7.  The protein kinase A pathway contributes to Hg2+-induced alterations in phosphorylation and subcellular distribution of occludin associated with increased tight junction permeability of salivary epithelial cell monolayers.

Authors:  Jitesh D Kawedia; Mengmeng Jiang; Amit Kulkarni; Holly E Waechter; Karl S Matlin; Giovanni M Pauletti; Anil G Menon
Journal:  J Pharmacol Exp Ther       Date:  2008-06-12       Impact factor: 4.030

Review 8.  Diagnosis and management of xerostomia and hyposalivation.

Authors:  Alessandro Villa; Christopher L Connell; Silvio Abati
Journal:  Ther Clin Risk Manag       Date:  2014-12-22       Impact factor: 2.423

Review 9.  Pulmonary defense and the human cathelicidin hCAP-18/LL-37.

Authors:  R J Fahy; M D Wewers
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 10.  A Review on Xerostomia and Its Various Management Strategies: The Role of Advanced Polymeric Materials in the Treatment Approaches.

Authors:  Afroditi Kapourani; Konstantinos N Kontogiannopoulos; Alexandra-Eleftheria Manioudaki; Athanasios K Poulopoulos; Lazaros Tsalikis; Andreana N Assimopoulou; Panagiotis Barmpalexis
Journal:  Polymers (Basel)       Date:  2022-02-22       Impact factor: 4.329
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.